Cite
Construction of an individualized clinical prognostic index based on ubiquitination-associated lncRNA in clear cell renal cell carcinoma patients.
MLA
Liu, Kun, et al. “Construction of an Individualized Clinical Prognostic Index Based on Ubiquitination-Associated LncRNA in Clear Cell Renal Cell Carcinoma Patients.” World Journal of Surgical Oncology, vol. 20, no. 1, May 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12957-022-02618-x.
APA
Liu, K., Liu, X., Sun, Q., Tang, Z., Wang, G., & Xu, Z. (2022). Construction of an individualized clinical prognostic index based on ubiquitination-associated lncRNA in clear cell renal cell carcinoma patients. World Journal of Surgical Oncology, 20(1), 1–10. https://doi.org/10.1186/s12957-022-02618-x
Chicago
Liu, Kun, Xuzhong Liu, Qing Sun, Zhiwang Tang, Gongcheng Wang, and Zongyuan Xu. 2022. “Construction of an Individualized Clinical Prognostic Index Based on Ubiquitination-Associated LncRNA in Clear Cell Renal Cell Carcinoma Patients.” World Journal of Surgical Oncology 20 (1): 1–10. doi:10.1186/s12957-022-02618-x.